drugset / Trial / NCT00550290

Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy

NCT00550290

Phase 4 Completed 18 enrolled Aultman Health Foundation
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized prospective study will specifically investigate the efficacy of a 24 hour post-operative course of broad-spectrum prophylactic antibiotics - namely Cefazolin - in preventing wound infection and wound breakdown following vulvectomy.

Timeline

Start
2007-10
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefazolin Small molecule 1 g Intravenous
Subject Cefazolin Small molecule 2 g Intravenous

Indications